113 related articles for article (PubMed ID: 17021051)
21. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
Doan T; Farmer P; Cooney T; Ali MS
Cell Signal; 2004 Mar; 16(3):301-11. PubMed ID: 14687660
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
23. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
24. Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia.
Kim HY; Park SJ; Joe EH; Jou I
J Biol Chem; 2006 Apr; 281(17):11872-8. PubMed ID: 16507579
[TBL] [Abstract][Full Text] [Related]
25. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
26. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
27. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2.
Hortala M; Ferjoux G; Estival A; Bertrand C; Schulz S; Pradayrol L; Susini C; Clemente F
J Biol Chem; 2003 Jun; 278(23):20574-81. PubMed ID: 12665520
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
Shaw S; Bencherif M; Marrero MB
J Neurosci; 2003 Dec; 23(35):11224-8. PubMed ID: 14657181
[TBL] [Abstract][Full Text] [Related]
31. Regulation of acidification and apoptosis by SHP-1 and Bcl-2.
Thangaraju M; Sharma K; Leber B; Andrews DW; Shen SH; Srikant CB
J Biol Chem; 1999 Oct; 274(41):29549-57. PubMed ID: 10506221
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases.
Yin T; Shen R; Feng GS; Yang YC
J Biol Chem; 1997 Jan; 272(2):1032-7. PubMed ID: 8995399
[TBL] [Abstract][Full Text] [Related]
33. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
Reardon DB; Dent P; Wood SL; Kong T; Sturgill TW
Mol Endocrinol; 1997 Jul; 11(8):1062-9. PubMed ID: 9212054
[TBL] [Abstract][Full Text] [Related]
34. Activation of SRC tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells.
Wang Q; Pfeiffer GR; Gaarde WA
J Biol Chem; 2003 Nov; 278(48):47731-43. PubMed ID: 14504278
[TBL] [Abstract][Full Text] [Related]
35. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
Massa A; Barbieri F; Aiello C; Arena S; Pattarozzi A; Pirani P; Corsaro A; Iuliano R; Fusco A; Zona G; Spaziante R; Florio T; Schettini G
J Biol Chem; 2004 Jul; 279(28):29004-12. PubMed ID: 15123617
[TBL] [Abstract][Full Text] [Related]
36. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC
Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253
[TBL] [Abstract][Full Text] [Related]
37. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530.
Egan C; Pang A; Durda D; Cheng HC; Wang JH; Fujita DJ
Oncogene; 1999 Feb; 18(5):1227-37. PubMed ID: 10022129
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.
Du Z; Shen Y; Yang W; Mecklenbrauker I; Neel BG; Ivashkiv LB
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10267-72. PubMed ID: 16000408
[TBL] [Abstract][Full Text] [Related]
39. Effective dephosphorylation of Src substrates by SHP-1.
Frank C; Burkhardt C; Imhof D; Ringel J; Zschörnig O; Wieligmann K; Zacharias M; Böhmer FD
J Biol Chem; 2004 Mar; 279(12):11375-83. PubMed ID: 14699166
[TBL] [Abstract][Full Text] [Related]
40. Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes.
Bordin L; Brunati AM; Donella-Deana A; Baggio B; Toninello A; Clari G
Blood; 2002 Jul; 100(1):276-82. PubMed ID: 12070037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
